Serial #79275300
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79275300 Trademark

Serial Number: 79275300 • Registration: 6182144

Serial #79275300 is a trademark filed by Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd. on September 24, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 30 (Staple Foods). The application is currently registered and active.

Owner Contact Info

Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd. (8 trademarks)

No 3, South of Kangtai Road,
Zhongshan 528437 , CN

Entity Type: 16

Trademark Details

Filing Date

September 24, 2019

Registration Date

October 27, 2020

Published for Opposition

August 11, 2020

Goods & Services

Cocoa preparations, namely, cocoa, cocoa powder; tea-based beverages; tea substitutes; sugar; ginseng candy; herbal jelly candy; instant edible bird's nest with sugar; loquat paste being fruit paste for flavoring food; confectionery, namely, candy; cooking salt; yeast; food flavorings being non-essential oils in the nature of citrus, fruit, mint, bean, spicy, milk flavor, meat flavor, nut, wine and vegetable essences for foodstuffs, except etheric essences and essential oils; vegetal preparations for use as coffee substitutes; tea; peppermint sweets; royal jelly for food purposes; breakfast cereal consisting of dried fruit and nuts; Processed cereal powder-based food; cereal preparations, namely, cereal bars; noodle-based prepared meals; cereal-based snack food; bean flour; starch for food; edible ices; vinegar; seasonings; gluten prepared as foodstuff for culinary purposes

Herbal teas for medicinal purposes; Medicine for human purpose for the treatment of gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; Nutritive substance for microorganisms for medical purposes; Capsules sold empty for medicines; Medicinal herbal tea; Chinese patent medicines for the treatment of gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; Injectable solutions for medical purposes for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; diet teas for medical purpose; medicated liquor; disinfectants; powdered milk for babies; dietetic substances adapted for medical use; air purifying preparations; Medicines for veterinary purposes for treating antimicrobial and anti-parasitic treatment, for promoting growth of animals and for the treatment of nervous, gastrointestinal, respiratory and metabolic system related diseases; vermin destroying preparations; mosquito-repellent incenses; preparations for destroying noxious animals; adhesive tapes for medical purposes; tissues impregnated with pharmaceutical lotions; teeth filling material; medicinal drinks; Pharmaceutical preparations for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; Decoctions for pharmaceutical purpose for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; digestives for pharmaceutical purposes; Active pharmaceutical ingredients, namely, pharmaceutical preparations for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; Radioactive pharmaceuticals for treating gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; gases for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; solutions for contact lenses; media for bacteriological cultures; candy, medicated; chewing gum for medical purposes

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 27, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Apr 23, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 21, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Feb 9, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 9, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 27, 2021 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 8, 2021 NREP
REGISTERED-PRINCIPAL REGISTER
Oct 27, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 11, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Aug 7, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 22, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 22, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 7, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 6, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 6, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 16, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 16, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 16, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 16, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 16, 2020 COAR
REFUSAL PROCESSED BY IB
Feb 22, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 6, 2020 RFCS
REFUSAL PROCESSED BY MPU
Feb 6, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 14, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jan 13, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 11, 2020 MAFR
ASSIGNED TO EXAMINER
Jan 7, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 26, 2019 REPR